Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated safety, tolerability, and pharmacokinetics of switching from oral risperidone to a risperidone implant in schizophrenia. Re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Risperidone (oral) (risperidone)
• Risperidone implant (risperidone)

Snippet

Sponsor: Delpor, Inc. | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-12-27